Tag: Synthetic Biologics Inc (NYSE: SYN)

Business

Synthetic Biologics Inc (NYSE: SYN) Delivers Update on SYN-020 Intestinal Alkaline Phosphatase Stage 1 Single-Ascending Dosage Scientific Pilot

Synthetic Biologics Inc (NYSE: SYN) today announced that patient medicating and scrutiny has been accomplished in its Stage 1, exposed label, single-ascending dose (SAD) scientific pilot of SYN-020 intestinal alkaline phosphatase (IAP). Stage 1 SAD study registered 24 fit grownup helpers The Stage 1 SAD study registered 24 fit adult […]